You are here :

  1. Home
  2. Investors
  3. Events & presentations
  4. Corporate events
  5. Events 2007
  6. Collaboration with Regeneron

Change language :

Français

Investors

Events & presentations

Collaboration with Regeneron

  • To print this page, please use the File menu or press simultaneously ctrl + p keys.
  • Send this page

November 29, 2007

The collaboration agreement with Regeneron to develop and commercialize fully-human therapeutic antibodies was presented by Mr. Jean-Claude Muller, Senior Vice President Administration and Resources, and Mr. Jean-Michel Lévy, Senior Vice President Business Development. The presentation was followed by a Q&A session.

 

Recorded audio webcast held on November 29 at 12 noon (CET)

Download documents

Euronext Paris (SAN)

Quote: €48.47. Level change: +1.42%
Last update: Sept 09, 2010 05.38 PM (CET)

NYSE (SNY)

Quote: $30.72. Level change: +1.52%
Last update: Sept 09, 2010 04.04 PM (EST)

Subscriptions